logo
episode-header-image
Jul 2023
14m 27s

AAN President Elect Testified Before Hou...

AMERICAN ACADEMY OF NEUROLOGY
About this episode

Dr. Stacey Clardy talks with Dr. Natalia Rost about her experience speaking before the House of Representatives on the approval of lecanemab for the treatment of early Alzheimer disease.

Visit NPUb.org/Podcast for associated article links.

This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

Up next
Yesterday
Resolution of PML after Treatment with Virus-Specific T Cells and HCT
Dr. Justin Abbatemarco talks with Dr. Irene Cortese about recent advances in the treatment of progressive multifocal leukoencephalopathy (PML), focusing on immune-based therapies like virus-specific T cells and immune checkpoint inhibitors. Read the related article in The New Eng ... Show More
21m 16s
Sep 21
Primary Motor Cortex Involvement and Seizure Risk in Patients With Brain Metastases
Dr. Kait Nevel talks with Drs. Ayal Aizer and Clara Baselga-Garriga about the link between primary motor cortex involvement in brain metastases and increased seizure risk, highlighting implications for patient management and future research directions. Read the related article in ... Show More
13m 28s
Sep 17
Marijuana Rescheduling: What It Means for Neurology Research and Care
Dr. John Ney talks with Dr. Daniele Piomelli about the evolving role of cannabis in neurology, exploring its history, current research, and potential future applications. Read the related article in The New England Journal of Medicine. Disclosures can be found at Neurology.org. 
27m 21s
Recommended Episodes
Jun 2025
Advancing Radiology for Early Alzheimer's Detection - Sponsored by Eli Lilly and Company
<p>In this episode, Dr. Ashwin Parihar speaks with Dr. Petrice Cogswell about the radiologist's critical role in diagnosing Alzheimer's disease and how imaging advances are reshaping early detection. They also explore how innovation at scale, platform thinking, and operational al ... Show More
20m 44s
Jun 2023
SOS Minute: Autoimmune Encephalitis
Drs. Stacey Clardy and Fabio Nascimento discuss the case of a patient with Autoimmune Encephalitis. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. 
4m 26s
Nov 2023
Alzheimer’s Update, Part 2
This episode explores the current state of research on the multiple likely mechanisms of Alzheimer’s disease as well as promising treatments and diagnostics. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2309944. 
54 m
Dec 2024
156| Updated Diagnosis and Staging Criteria for Alzheimer's Disease – A Conversation with Dr. Cliff Jack and Dr. Kevin Duff
<p class="MsoNormal">This episode is a conversation with Drs. Clifford Jack and Kevin Duff about recent updates to the diagnosis and staging of Alzheimer's disease (AD). We discuss biological versus clinical/pathological approaches to diagnosing AD, analogies between AD and other ... Show More
1h 44m
Apr 2024
Dementia News Roundup - Frankly Speaking Ep 378
<p>Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-378'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-378</a></p> <p>Overview: Effective treatmen ... Show More
10m 37s
Mar 2024
Lecanemab in Alzheimer Disease
<p>Dr. Jason Crowell talks with Dr. Anelyssa D' Abreu about her recently posted NeuroByte on key features in Lecanemab. </p> <p>Watch the <a href="https://learning.aan.com/courses/62800" target="_blank" rel="noopener">NeuroByte now</a>! </p> 
4 m
Sep 2024
The Dual Advantage: Improving Alzheimer Care with Combination Therapy - Frankly Speaking Ep 399
<p>Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399</a></p> <p>Overview: In this episode, w ... Show More
10m 17s
Aug 2023
Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease
<p>In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease.<br /> <br /> <stron ... Show More
28m 48s
Feb 2024
The 2 Minute Medicine® Podcast- Episode 35
<p>We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-c ... Show More
11m 48s
Sep 2024
Neuroimaging in the Era of Anti-Amyloid Therapies - Sponsored by GE HealthCare
Dr. Linda Chu speaks with Dr. Giuseppe Esposito, Dr. Yasar Torres-Yaghi, and Dr. Lydia Wood to explore how the availability of amyloid PET imaging and other advanced neuroimaging techniques is transforming the diagnostic and treatment landscape for neurodegenerative disorders. Sp ... Show More
50m 15s